Stephanie Christenson, MD MAS
Dr. Christenson is an Associate Professor at the University of California, San Francisco in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine where she serves as an attending physician in the Pulmonary Clinic and on the Consult Service. Dr. Christenson’s research program integrates genomics/bioinformatics and clinical research to study chronic airway disease. Dr. Christenson also serves in multiple leadership roles for multi-center studies and advises industry on trials of biologic and inhaled therapies for COPD. Leadership roles include co-director of the Genetics and Genomics Subcommittee for the multi-center SPIROMICS and SOURCE studies, the UCSF site PI for the American Lung Association (ALA) Airway Clinical Research Consortium, and co-Chair for the NHGRI-funded Multi-Omics in Health and Disease (MOHD) Consortium.
Financial relationships
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:Uniquity BioTopic:COPDDate added:03/04/2026Date updated:03/04/2026Relationship end date:03/01/2027
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:SanofiTopic:Asthma/COPDDate added:03/04/2026Date updated:03/04/2026
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:SanofiTopic:COPDDate added:03/04/2026Date updated:03/04/2026Relationship end date:09/30/2025
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:RegeneronTopic:COPDDate added:03/04/2026Date updated:03/04/2026
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:RegeneronTopic:COPDDate added:03/04/2026Date updated:03/04/2026Relationship end date:09/30/2025
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:AstraZenecaTopic:Asthma/COPDDate added:03/04/2026Date updated:03/04/2026
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:AstraZenecaTopic:Asthma/COPDDate added:03/04/2026Date updated:03/04/2026Relationship end date:09/30/2025
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:AbbvieTopic:Asthma/COPDDate added:03/04/2026Date updated:03/04/2026
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:Apogee TherapeuticsTopic:Asthma/COPDDate added:03/04/2026Date updated:03/04/2026
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:GenentechTopic:Asthma/COPDDate added:03/04/2026Date updated:03/04/2026

Facebook
X
LinkedIn
Forward